Related Experiment Video
Updated: Apr 2, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
16.7K
Depression--An emerging indication for botulinum toxin treatment
Tillmann H C Kruger1, M Axel Wollmer2
1Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover, Germany.
Toxicon : Official Journal of the International Society on Toxinology
|September 30, 2015
Summary
Botulinum toxin injections, commonly used for cosmetic frown lines, show promising results in treating depression. This treatment may offer rapid, sustained mood improvement for patients with unipolar depression.
Area of Science:
- Aesthetic medicine and psychiatry
- Neuromodulation and affective disorders
Background:
- Botulinum toxin injections are popular for cosmetic glabellar frown lines.
- Emerging evidence suggests potential mood-modulatory effects beyond aesthetics.
Purpose of the Study:
- To investigate the efficacy of botulinum toxin A in treating depression.
- To explore the potential psychiatric applications of botulinum toxin.
Main Methods:
- Review of recent studies, including three randomized controlled trials.
- Treatment involved single glabellar injections of botulinum toxin A.
Main Results:
- Consistent findings show significant improvement in depressive symptoms.
- Predominantly female patients with treatment-resistant unipolar depression experienced rapid, strong, and sustained relief.
- Botulinum toxin A was effective as a sole or adjunctive therapy.
Conclusions:
- Botulinum toxin A demonstrates potential as a novel therapeutic option for depression.
- Further research may expand its use into psychiatric treatment, possibly via proprioceptive feedback mechanisms affecting the emotional brain.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:30Electroconvulsive Therapy
2.1K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.1K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:05Long-term Depression
33.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.8K